Sonnet BioTherapeutics Holdings, Inc.

CIK 1106838 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sonnet BioTherapeutics Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Jul 17, 202610-K/A0001493152-26-033712
Dec 16, 2025EFFECT9999999995-25-003748
Dec 16, 202510-K0001493152-25-027978
Dec 16, 2025EFFECT9999999995-25-003782
Dec 16, 2025EFFECT9999999995-25-003762
Dec 16, 2025EFFECT9999999995-25-003783
Dec 16, 2025EFFECT9999999995-25-003768
Dec 16, 2025EFFECT9999999995-25-003764
Dec 16, 2025EFFECT9999999995-25-003763
Dec 16, 2025EFFECT9999999995-25-003774
Dec 16, 2025EFFECT9999999995-25-003773
Dec 16, 2025EFFECT9999999995-25-003754
Dec 16, 2025EFFECT9999999995-25-003772
Dec 16, 2025EFFECT9999999995-25-003775
Dec 16, 2025EFFECT9999999995-25-003777
Dec 16, 202515-12G0001493152-25-027980
Dec 16, 2025EFFECT9999999995-25-003766
Dec 16, 2025EFFECT9999999995-25-003767
Dec 16, 2025EFFECT9999999995-25-003749
Dec 16, 2025EFFECT9999999995-25-003753
Dec 16, 2025EFFECT9999999995-25-003752
Dec 16, 2025EFFECT9999999995-25-003756
Dec 16, 2025EFFECT9999999995-25-003747
Dec 16, 2025EFFECT9999999995-25-003755
Dec 16, 2025EFFECT9999999995-25-003751